Champions Oncology, Inc.
CSBRNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $67.54M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.59$8.31
- Volume (live)
- -
- Avg. volume (3M)
- 11.95K
Champions Oncology (CSBR) Stock Price & Financial Analysis
Champions Oncology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.80 - $5.03 |
|---|---|
| 52-Week High | $8.31 |
| 52-Week Low | $4.59 |
| Open | $4.80 |
| Volume (last close) | 15.13K |
| Average Volume (3M) | 11.95K |
| Revenue (TTM) | 60.66M |
|---|---|
| Net Income (TTM) | -1.07M |
| Free Cash Flow (TTM) | -6.14M |
| EPS (TTM) | −$0.08 |
| Profit Margin | -1.77% |
| Operating Margin | -1.54% |
| Return on Equity (ROE) | -24.06% |
| Debt to Equity | 2.46 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 67.54M |
|---|---|
| Shares Outstanding | 13.90M |
| Price to Sales (P/S) | 1.11 |
| Price to Book (P/B) | 15.14 |
| EV/EBITDA | 181.46 |
| 50-Day MA | $4.99 |
|---|---|
| 200-Day MA | $5.83 |
| 1-Year Change | −29.48% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Champions Oncology at a Glance
As of the Oct 26, 2026 close, Champions Oncology (CSBR) has a market capitalization of $67.54M. The stock trades at 1.1× sales. Over the trailing twelve months it lost $1.07M on revenue of $60.66M and burned $6.14M of free cash flow. Revenue grew 6.7% year over year.
As of its latest reported balance sheet, it holds $4.36M in cash and securities against $10.97M of debt, a net debt position of $6.61M.
Champions Oncology does not currently pay a dividend.
The share price is down 29.5% over the past year. At $4.86 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $4.59 to $8.31, below its 200-day moving average of $5.83.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Champions Oncology
What is the current stock price for CSBR?
As of the Oct 26, 2026 close, CSBR stock trades at $4.86. The 52-week range is $4.59–$8.31, with a day range of $4.80–$5.03.
What is the P/E ratio for CSBR?
The P/E ratio (Price-to-Earnings) for CSBR is shown in the Key Statistics section. This valuation metric helps compare Champions Oncology, Inc. to industry peers.
Does CSBR pay dividends?
Champions Oncology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CSBR?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for CSBR is Buy.
What is the market cap of CSBR?
As of the Oct 26, 2026 close, Champions Oncology's market capitalization is $67.5M, classifying it as a micro-cap company. Champions Oncology operates in the Healthcare sector within the Biotechnology industry.